BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abuodeh Y, Naghavi AO, Ahmed KA, Venkat PS, Kim Y, Kis B, Choi J, Biebel B, Sweeney J, Anaya DA, Kim R, Malafa M, Frakes JM, Hoffe SE, El-Haddad G. Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization. World J Gastroenterol 2016; 22(47): 10406-10414 [PMID: 28058021 DOI: 10.3748/wjg.v22.i47.10406]
URL: https://www.wjgnet.com/1007-9327/full/v22/i47/10406.htm
Number Citing Articles
1
Sang Mi Lee, Hong Soo Kim, Sangheun Lee, Jeong Won Lee. Emerging role of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(11): 1289-1306 doi: 10.3748/wjg.v25.i11.1289
2
Rania Refaat, Mohammad Abd Alkhalik Basha, Mohammed Sobhi Hassan, Rasha S. Hussein, Ahmed A. El Sammak, Dena Abd El Aziz El Sammak, Mohamed Hesham Saleh Radwan, Nahla M. Awad, Somaia A. Saad El-Din, Engi Elkholy, Dina R. D. Ibrahim, Shereen A. Saleh, Iman F. Montasser, Hany Said. Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinomaEuropean Radiology 2018; 28(12) doi: 10.1007/s00330-018-5425-z
3
Remco Bastiaannet, Martin A. Lodge, Hugo W.A.M. de Jong, Marnix G.E.H. Lam. The Unique Role of Fluorodeoxyglucose-PET in RadioembolizationPET Clinics 2019; 14(4) doi: 10.1016/j.cpet.2019.06.002
4
Alice Boilève, Marc Hilmi, Matthieu Delaye, Annemilaï Tijeras-Raballand, Cindy Neuzillet. Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?Cancers 2021; 13(11) doi: 10.3390/cancers13112708
5
Sang Hyun Hwang, Hye-Suk Hong, Dongwoo Kim, Gyoung Min Kim, Hye Won Lee, Misu Lee, Do Young Kim, Mi-Ae Park, Mijin Yun. Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial RadioembolizationClinical Nuclear Medicine 2022; 47(6) doi: 10.1097/RLU.0000000000004128
6
Paul Blanc-Durand, Axel Van Der Gucht, Mario Jreige, Marie Nicod-Lalonde, Marina Silva-Monteiro, John O. Prior, Alban Denys, Adrien Depeursinge, Niklaus Schaefer. Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinomaOncotarget 2018; 9(4) doi: 10.18632/oncotarget.23423
7
Angelo Castello, Egesta Lopci. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utilityClinical and Translational Imaging 2020; 8(5) doi: 10.1007/s40336-020-00384-y
8
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal MalignanciesRadiologic Clinics of North America 2021; 59(5) doi: 10.1016/j.rcl.2021.06.001
9
Maria Stella Franzè, Paul Vigneron, Anna Sessa, Carlo Saitta, Julia Chalaye, Vania Tacher, Alain Luciani, Hélène Regnault, Ancuta Bejan, Rami Rhaiem, Daniele Sommacale, Vincent Leroy, Raffaele Brustia, Giovanni Raimondo, Giuliana Amaddeo. Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapyAnnals of Hepatology 2025; 30(1) doi: 10.1016/j.aohep.2024.101539
10
K. V. Lyadov, A. D. Kaprin, A. G. Rerberg, I. A. Kozyrin, V. K. Lyadov, K. V. Maiorov, D. A. Kaprin, O. V. Moroz, D. V. Cherednichenko, I. Yu. Dobreva, V. G. Polushkin, A. A. Khodovsky. Therapy for inoperable hepatocellular carcinoma with selective transarterial radioembolization with yttrium-90 microspheresOnkologiya. Zhurnal imeni P.A.Gertsena 2018; 7(3) doi: 10.17116/onkolog20187355
11
Ji Hye Min, Mohammad Saeid Rezaee-Zavareh, Abdelrahman M. Attia, Soo Young Hwang, Pin-Jung Chen, Tamar Yalda, Hasmik Adetyan, Rami Hemadeh, Hyun-seok Kim, Bachir Taouli, Amit G. Singal, Ju Dong Yang. Prognostic Significance of Pretreatment 18F-FDG PET/CT in Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisJHEP Reports 2026;  doi: 10.1016/j.jhepr.2026.101901
12
Huanyu Gong, Yong Cheng, Qiang Li, Yulong Liu, Jingjie Shang, Yingxin Li, Lu Kuang, Xueying Ling, Changjing Zuo, Lu Wang, Jian Gong, Hao Xu. The predictive value of 18F-FAPI PET/CT and voxel-based tumor absorbed dose for the response and clinical outcome of unresectable hepatocellular carcinoma patients treated with Yttrium-90 resin microsphere selective internal radiation therapyEuropean Journal of Nuclear Medicine and Molecular Imaging 2026; 53(6) doi: 10.1007/s00259-025-07717-x
13
Kenta Maruyama, Hiroyasu Kidoya, Naoki Takemura, Erika Sugisawa, Osamu Takeuchi, Takeshi Kondo, Mohammed Mansour Abbas Eid, Hiroki Tanaka, Mikaël M. Martino, Nobuyuki Takakura, Yasunori Takayama, Shizuo Akira, Alexis Vandenbon, Yutaro Kumagai. Zinc Finger Protein St18 Protects against Septic Death by Inhibiting VEGF-A from MacrophagesCell Reports 2020; 32(2) doi: 10.1016/j.celrep.2020.107906
14
Vincent Vinh-Hung, Hendrik Everaert, Karim Farid, Navid Djassemi, Jacqueline Baudin-Veronique, Stefanos Bougas, Yuriy Michailovich, Clarisse Joachim-Contaret, Elsa Cécilia-Joseph, Claire Verschraegen, Nam P Nguyen. Preoperative [18]fluorodeoxyglucose-positron emission tomography/computed tomography in early stage breast cancer: Rates of distant metastasesWorld Journal of Radiology 2017; 9(7): 312-320 doi: 10.4329/wjr.v9.i7.312
15
Kyung Jin Cho, Nam Kyu Choi, Min Ho Shin, A Ri Chong. Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resectionAnnals of Hepato-Biliary-Pancreatic Surgery 2017; 21(4) doi: 10.14701/ahbps.2017.21.4.194
16
Philippe d’Abadie, Stephan Walrand, Renaud Lhommel, Michel Hesse, Ivan Borbath, François Jamar. Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection CriteriaCurrent Oncology 2022; 29(4) doi: 10.3390/curroncol29040196
17
Samar Ramzy Ragheb, Amr Mahmoud Ahmed Abelsamad, Moustafa Mahmoud Abelkawy, Osama Abu Elnaga Khalaf Nasr. Role of PET/CT in patients with unexplained rising alpha fetoprotein post HCC interventional managementEgyptian Journal of Radiology and Nuclear Medicine 2020; 51(1) doi: 10.1186/s43055-020-00158-6
18
Justine Perrin, Karim Farid, Hilde Van Parijs, Olena Gorobets, Vincent Vinh-Hung, Nam P Nguyen, Navid Djassemi, Mark De Ridder, Hendrik Everaert. Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysisWorld Journal of Clinical Oncology 2022; 13(4): 287-302 doi: 10.5306/wjco.v13.i4.287